Crossmark

Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development

Crossref DOI link: https://doi.org/10.1186/s12879-025-11227-4

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Chen

Dai, Guangchuan

Guo, Yicheng

Wang, Tianzhen

Gao, Weiwei

Zeng, Yi
Funding

Funding for this research was provided by:

the Nanjing Health Science and Technology Development Special Fund (M2021073)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 14 February 2025

Accepted: 10 June 2025

First Online: 1 July 2025

Declarations

:

: The study received approval from the Human Research Ethics and System Review Committee of the Second Hospital of Nanjing (ID: 2024-LS-ky026). The study protocol was consistent with the ethical guidelines of the 1975 Declaration of Helsinki.

: Informed consent was obtained from all the participants.

: Not applicable.

: All authors have no conflict of interest to declare.

: Not Applicable.

Document is current

Any future updates will be listed below